Scientists discovered that when people have chronic kidney disease, their gut bacteria can become unbalanced in ways that increase the risk of irregular heartbeats. Using rat studies, researchers found that unhealthy gut bacteria produce harmful substances that leak into the bloodstream and trigger inflammation in the heart. The good news? Treating the gut with specific probiotics or protective compounds prevented these heart problems from developing. This research suggests that managing gut health could become a new way to prevent dangerous heart rhythm problems in people with kidney disease.
The Quick Take
- What they studied: Whether unhealthy gut bacteria in people with kidney disease causes irregular heartbeats, and if fixing the gut bacteria could prevent this problem
- Who participated: Laboratory rats with artificially induced chronic kidney disease, plus healthy rats that received transplants of bacteria from sick rats
- Key finding: Rats with kidney disease developed irregular heartbeats linked to imbalanced gut bacteria. When healthy rats received bacteria from sick rats, they also developed irregular heartbeats. Treating the gut with specific probiotics or protective compounds prevented these heart problems.
- What it means for you: This suggests that people with kidney disease might be able to reduce their heart rhythm problems by improving their gut health through probiotics or other gut-protective treatments. However, this is early-stage research in animals, and human studies are needed before doctors can recommend these treatments.
The Research Details
Researchers created a rat model of chronic kidney disease by feeding them a special diet high in adenine (a compound that damages kidneys). They then studied the bacteria living in these rats’ guts using genetic sequencing technology. To prove that the bacteria themselves caused the heart problems, they transferred gut bacteria from sick rats into healthy rats and watched whether the healthy rats developed irregular heartbeats. They also tested several treatments: a compound called AST-120 that removes harmful bacterial byproducts, protective substances that strengthen the gut barrier, and a specific probiotic called Lactobacillus gasseri.
The researchers used advanced techniques to identify exactly which bacteria were present and how they changed. They measured harmful substances in the blood and tracked heart rhythm problems using standard monitoring methods. This multi-step approach allowed them to not only show that bacteria were involved, but also to identify the specific chain of events causing the heart problems.
This research design is powerful because it goes beyond just observing that sick people have both bad bacteria and heart problems. By transferring bacteria from sick rats to healthy rats and seeing the same heart problems develop, the researchers proved that the bacteria themselves cause the problem, not just that they appear together. This is crucial for understanding whether treating the bacteria could actually prevent heart disease.
This is animal research, which means the findings may not directly apply to humans. However, the study used multiple complementary approaches (genetic analysis, bacterial transplants, and treatment trials) that all pointed to the same conclusion, which strengthens confidence in the results. The researchers tested specific treatments and showed they worked, which is a strong indicator of scientific rigor. The main limitation is that these are rats, not people, so human studies are needed to confirm these findings apply to patients.
What the Results Show
Rats with chronic kidney disease showed significant changes in their gut bacteria—specifically, a loss of healthy bacteria and an increase in harmful ones. These rats developed irregular heartbeats at much higher rates than healthy control rats. When researchers transferred gut bacteria from the sick rats into healthy rats, the healthy rats also developed irregular heartbeats, proving that the bacteria themselves were responsible for the heart problems.
The mechanism worked like this: unhealthy gut bacteria produce a toxic substance called indoxyl sulfate (IS). This substance damages the intestinal barrier, allowing harmful bacterial components called lipopolysaccharides (LPS) to leak into the bloodstream. These LPS molecules travel to the heart and activate a danger alarm system called the NLRP3 inflammasome, which causes inflammation and disrupts the heart’s electrical system, leading to irregular beats.
When researchers treated the rats with AST-120 (a compound that removes IS from the body) or with protective substances that strengthen the gut barrier, the rats did not develop irregular heartbeats. Additionally, supplementing with Lactobacillus gasseri, a beneficial probiotic bacteria, reduced harmful IS levels and prevented heart rhythm problems.
The study showed that the specific chain of events—from dysbiosis to IS production to gut barrier damage to LPS leakage to heart inflammation—was essential. Breaking this chain at any point (by removing IS, protecting the gut barrier, or adding good bacteria) prevented heart problems. This suggests multiple potential treatment targets.
Previous research had shown that kidney disease increases heart rhythm problems and that gut bacteria change in kidney disease, but the connection between these two observations was unclear. This study fills that gap by demonstrating the specific mechanism linking them. It also aligns with growing evidence that gut health affects heart health through multiple pathways.
This research was conducted entirely in rats, not humans. Rats may respond differently to treatments than people would. The study used artificially induced kidney disease, which may not perfectly match the natural disease in humans. Additionally, the sample size and specific rat strains used were not detailed in the abstract. Before these findings can be applied to patient care, human clinical trials would be necessary to confirm that the same mechanisms operate in people and that the treatments are safe and effective.
The Bottom Line
Based on this research, people with chronic kidney disease should discuss gut health with their doctors. While probiotics like Lactobacillus gasseri show promise in this animal research, they should not be started without medical guidance. Maintaining overall gut health through a balanced diet rich in fiber and fermented foods may be beneficial, but this is a general recommendation, not specific to this study. Doctors may eventually recommend specific probiotic treatments or gut-protective compounds, but more human research is needed first. Confidence level: Low to Moderate (animal research only).
This research is most relevant to people with chronic kidney disease who are at risk for or have experienced irregular heartbeats. It may also interest cardiologists and nephrologists (kidney doctors) who treat these patients. People without kidney disease should not assume these findings apply to them. Patients should discuss any new treatments with their healthcare team before starting.
In the rat studies, treatments prevented heart problems when given before they developed. If similar treatments become available for humans, benefits might take weeks to months to appear, as the gut bacteria need time to rebalance and inflammation needs time to decrease. This is not a quick fix.
Want to Apply This Research?
- Users with chronic kidney disease could track their heart rhythm symptoms (palpitations, skipped beats, or irregular sensations) weekly using a simple 1-10 scale, along with their probiotic or gut health supplement intake, to monitor whether interventions correlate with symptom changes over time.
- Users could set a daily reminder to take a probiotic supplement (if recommended by their doctor), track their fiber intake from whole grains and vegetables, and log any heart rhythm symptoms. The app could provide education about which foods support healthy gut bacteria.
- Over 8-12 weeks, users could monitor trends in heart rhythm symptoms while maintaining consistent probiotic use and dietary changes. They could share this data with their doctor to assess whether gut-focused interventions are helping their specific situation.
This research is based on animal studies and has not yet been tested in humans. The findings are promising but preliminary. Anyone with chronic kidney disease or heart rhythm problems should consult with their healthcare provider before starting any new supplements, probiotics, or treatments based on this research. This information is educational and should not replace professional medical advice. Do not stop or change any current medications or treatments without talking to your doctor first.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.